Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Nov;51(11):2948–2958. doi: 10.1172/JCI107119

Effect of transfer factor on lymphocyte function in anergic patients

Charles H Kirkpatrick 1, Robert R Rich 1, Terrill K Smith 1
PMCID: PMC292445  PMID: 5080419

Abstract

Dialyzable transfer factor, obtained from frozen-thawed peripheral blood leukocytes from a single donor, was given to five anergic patients with chronic mucocutaneous candidiasis. Studies of immunological responses including delayed cutaneous hypersensitivity, in vitro antigen-induced thymidine incorporation, and production of macrophage migration inhibition factor (MIF) were conducted both before and after injection of transfer factor.

Before transfer factor, none of the patients had delayed skin responses to any of the natural antigens studied. Their lymphocytes did not produce MIF after exposure to antigens in vitro and only one patient showed increased thymidine incorporation when his lymphocytes were cultured with candida and streptokinase-streptodornase (SK-SD). After injection of transfer factor, four patients developed delayed skin responses to antigens to which the donor was sensitive; no recipient reacted to an antigen to which the donor was nonreactive. Lymphocytes from recipients produced MIF when cultured with antigens that evoked positive delayed skin tests. Only one patient developed antigen-induced lymphocyte transformation and this response occurred only intermittently. Attempts to sensitize three of the patients with the contact allergen, chlorodinitrobenzene, both before and after transfer factor, were unsuccessful.

The fifth patient, a 9-yr old boy with an immunologic profile similar to the Nezelof syndrome, did not become skin test-reactive or develop positive responses to the in vitro tests.

These findings suggest that transfer factor acts on the immunocompetent cells that respond to antigens with lymphokine production, but has little, if any, effect on cells that respond to antigens by blastogenesis. The failure to sensitize the subjects with chlorodinitrobenzene illustrates the specificity of the immunologic effects of transfer factor, and implies that it does not function through nonspecific, adjuvant-like mechanisms. Failure of transfer factor to produce positive skin tests or MIF production in a patient with Nezelof's syndrome may be evidence that lymphokine-producing cells are thymus derived.

Full text

PDF
2948

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. August C. S., Berkel A. I., Levey R. H., Rosen F. S., Kay H. E. Establishment of immunological competence in a child with congenital thymic aplasia by a graft of fetal thymus. Lancet. 1970 May 23;1(7656):1080–1083. doi: 10.1016/s0140-6736(70)92755-8. [DOI] [PubMed] [Google Scholar]
  2. Bach F. H., Voynow N. K. One-way stimulation in mixed leukocyte cultures. Science. 1966 Jul 29;153(3735):545–547. doi: 10.1126/science.153.3735.545. [DOI] [PubMed] [Google Scholar]
  3. Bloom B. R. In vitro approaches to the mechanism of cell-mediated immune reactions. Adv Immunol. 1971;13:101–208. doi: 10.1016/s0065-2776(08)60184-4. [DOI] [PubMed] [Google Scholar]
  4. Buckley R. H., Lucas Z. J., Hattler B. G., Jr, Zmijewski C. M., Amos D. B. Defective cellular immunity associated with chronic mucocutaneous moniliasis and recurrent staphylococcal botryomycosis: immunological reconstitution by allogeneic bone marrow. Clin Exp Immunol. 1968 Feb;3(2):153–169. [PMC free article] [PubMed] [Google Scholar]
  5. Buckner D., Graw R. G., Jr, Eisel R. J., Henderson E. S., Perry S. Leukapheresis by continuous flow centrifugation (CFC) in patients with chronic myelocytic leukemia (CML). Blood. 1969 Feb;33(2):353–369. [PubMed] [Google Scholar]
  6. Canales L., Middlemas R. O., 3rd, Louro J. M., South M. A. Immunological observations in chronic mucocutaneous candidiasis. Lancet. 1969 Sep 13;2(7620):567–571. doi: 10.1016/s0140-6736(69)90264-5. [DOI] [PubMed] [Google Scholar]
  7. Catalona W. J., Taylor P. T., Rabson A. S., Chretien P. B. A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med. 1972 Feb 24;286(8):399–402. doi: 10.1056/NEJM197202242860804. [DOI] [PubMed] [Google Scholar]
  8. Chilgren R. A., Quie P. G., Meuwissen H. J., Hong R. Chronic mucocutaneous candidiasis, deficiency of delayed hypersensitivity, and selective local antibody defect. Lancet. 1967 Sep 30;2(7518):688–693. doi: 10.1016/s0140-6736(67)90974-9. [DOI] [PubMed] [Google Scholar]
  9. Claman H. N., Chaperon E. A. Immunologic complementation between thymus and marrow cells--a model for the two-cell theory of immunocompetence. Transplant Rev. 1969;1:92–113. doi: 10.1111/j.1600-065x.1969.tb00137.x. [DOI] [PubMed] [Google Scholar]
  10. Cleveland W. W., Fogel B. J., Brown W. T., Kay H. E. Foetal thymic transplant in a case of Digeorge's syndrome. Lancet. 1968 Dec 7;2(7580):1211–1214. doi: 10.1016/s0140-6736(68)91694-2. [DOI] [PubMed] [Google Scholar]
  11. Fireman P., Boesman M., Haddad Z. H., Gitlin D. Passive transfer of tuberculin reactivity in vitro. Science. 1967 Jan 20;155(3760):337–338. doi: 10.1126/science.155.3760.337. [DOI] [PubMed] [Google Scholar]
  12. Goldberg L. S., Bluestone R., Barnett E. V., Landau J. W. Studies on lymphocyte and monocyte function in chronic mucocutaneous candidiasis. Clin Exp Immunol. 1971 Jan;8(1):37–43. [PMC free article] [PubMed] [Google Scholar]
  13. JENSEN K., PATNODE R. A., TOWNSLEY H. C., CUMMINGS M. M. Multiple passive transfer of the delayed type of hypersensitivity in humans. Am Rev Respir Dis. 1962 Mar;85:373–377. doi: 10.1164/arrd.1962.85.3.373. [DOI] [PubMed] [Google Scholar]
  14. KIRKPATRICK C. H., WILSON W. E., TALMAGE D. W. IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA. J Exp Med. 1964 May 1;119:727–742. doi: 10.1084/jem.119.5.727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kirkpatrick C. H., Chandler J. W., Schimke R. N. Chronic mucocutaneous moniliasis with impaired delayed hypersensitivity. Clin Exp Immunol. 1970 Mar;6(3):375–385. [PMC free article] [PubMed] [Google Scholar]
  16. Kirkpatrick C. H., Rich R. R., Bennett J. E. Chronic mucocutaneous candidiasis: model-building in cellular immunity. Ann Intern Med. 1971 Jun;74(6):955–978. doi: 10.7326/0003-4819-74-6-955. [DOI] [PubMed] [Google Scholar]
  17. Kirkpatrick C. H., Rich R. R., Graw R. G., Jr, Smith T. K., Mickenberg I., Rogentine G. N. Treatment of chronic mucocutaneous moniliasis by immunologic reconstitution. Clin Exp Immunol. 1971 Dec;9(6):733–748. [PMC free article] [PubMed] [Google Scholar]
  18. LAWRENCE H. S. The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. J Clin Invest. 1955 Feb;34(2):219–230. doi: 10.1172/JCI103075. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lawrence H. S. Transfer factor. Adv Immunol. 1969;11:195–266. doi: 10.1016/s0065-2776(08)60480-0. [DOI] [PubMed] [Google Scholar]
  20. Levin A. S., Spitler L. E., Stites D. P., Fudenberg H. H. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: clinical and laboratory responses to therapy with transfer factor. Proc Natl Acad Sci U S A. 1970 Oct;67(2):821–828. doi: 10.1073/pnas.67.2.821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Levy R. L., Bach M. L., Huang S., Bach F. H., Hong R., Ammann A. J., Bortin M., Kay H. E. Thymic transplantation in a case of chronic mucocutaneous candidiasis. Lancet. 1971 Oct 23;2(7730):898–900. doi: 10.1016/s0140-6736(71)92503-7. [DOI] [PubMed] [Google Scholar]
  22. Louria D. B., Smith J. K., Brayton R. G., Buse M. Anti-Candida factors in serum and their inhibitors. I. Clinical and laboratory observations. J Infect Dis. 1972 Feb;125(2):102–114. doi: 10.1093/infdis/125.2.102. [DOI] [PubMed] [Google Scholar]
  23. Maize J. C., Lynch P. J. Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. Arch Dermatol. 1972 Jan;105(1):96–98. [PubMed] [Google Scholar]
  24. Meuwissen H. J., Rodey G., McArthur J., Pabst H., Gatti R., Chilgren R., Hong R., Frommel D., Coifman R., Good R. A. Bone marrow transplantation. Therapeutic usefulness and complications. Am J Med. 1971 Oct;51(4):513–532. doi: 10.1016/0002-9343(71)90257-9. [DOI] [PubMed] [Google Scholar]
  25. Montes L. F., Cooper M. D., Bradford L. G., Lauderdale R. O., Taylor C. D. Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B. Arch Dermatol. 1971 Jul;104(1):45–56. [PubMed] [Google Scholar]
  26. Newberry W. M., Jr, Chandler J. W., Jr, Chin T. D., Kirkpatrick C. H. Immunology of the mycoses. I. Depressed lymphocyte transformation in chronic histoplasmosis. J Immunol. 1968 Feb;100(2):436–443. [PubMed] [Google Scholar]
  27. Pabst H. F., Swanson R. Successful treatment of candidiasis with transfer factor. Br Med J. 1972 May 20;2(5811):442–443. doi: 10.1136/bmj.2.5811.442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Paterson P. Y., Semo R., Blumenschein G., Swelstad J. Mucocutaneous candidiasis, anergy and a plasma inhibitor of cellular immunity: reversal after amphotericin B therapy. Clin Exp Immunol. 1971 Nov;9(5):595–602. [PMC free article] [PubMed] [Google Scholar]
  29. Rocklin R. E., Chilgren R. A., Hong R., David J. R. Transfer of cellular hypersensitivity in chronic mucocutaneous candidiasis monitored in vivo and in vitro. Cell Immunol. 1970 Sep;1(3):290–299. doi: 10.1016/0008-8749(70)90050-x. [DOI] [PubMed] [Google Scholar]
  30. Rocklin R. E., Meyers O. L., David J. R. An in vitro assay for cellular hypersensitivity in man. J Immunol. 1970 Jan;104(1):95–102. [PubMed] [Google Scholar]
  31. Schoch E. P., Jr Thymic conversion of Candida albicans from commensalism to pathogenism. Arch Dermatol. 1971 Mar;103(3):311–319. [PubMed] [Google Scholar]
  32. Schulking M. L., Adler W. H., 3rd, Altemeier W. A., 3rd, Ayoub E. M. Transfer factor in the treatment of a case of chronic mucocutaneous candidiasis. Cell Immunol. 1972 Apr;3(4):606–615. doi: 10.1016/0008-8749(72)90122-0. [DOI] [PubMed] [Google Scholar]
  33. Schwartz H. J., Catanzaro P. J., Leon M. A. An analysis of the effects of skin reactive factor released from lymphoid cells by concanavalin A in vivo. Am J Pathol. 1971 Jun;63(3):443–462. [PMC free article] [PubMed] [Google Scholar]
  34. Shadomy S. In vitro antifungal activity of clotrimazole (Bay b 5097). Infect Immun. 1971 Aug;4(2):143–148. doi: 10.1128/iai.4.2.143-148.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Valdimarsson H., Holt L., Riches H. R., Hobbs J. R. Lymphocyte abnormality in chronic mucocutaneous candidiasis. Lancet. 1970 Jun 13;1(7659):1259–1261. doi: 10.1016/s0140-6736(70)91742-3. [DOI] [PubMed] [Google Scholar]
  36. WARWICK W. J., GOOD R. A., SMITH R. T. Failure of passive transfer of delayed hypersensitivity in the newborn human infant. J Lab Clin Med. 1960 Jul;56:139–147. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES